These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16823094)

  • 21. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients.
    Bleyer AJ; Burke SK; Dillon M; Garrett B; Kant KS; Lynch D; Rahman SN; Schoenfeld P; Teitelbaum I; Zeig S; Slatopolsky E
    Am J Kidney Dis; 1999 Apr; 33(4):694-701. PubMed ID: 10196011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients].
    Nagano N; Fukushima N
    Nihon Yakurigaku Zasshi; 2003 Nov; 122(5):443-53. PubMed ID: 14569164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospitalization risks between Renagel phosphate binder treated and non-Renagel treated patients.
    Collins AJ; St Peter WL; Dalleska FW; Ebben JP; Ma JZ
    Clin Nephrol; 2000 Oct; 54(4):334-41. PubMed ID: 11076110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
    Nolan CR; Qunibi WY
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):373-9. PubMed ID: 12815333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sevelamer hydrochloride binds phosphate released from phytate in chicks fed 1α-hydroxy cholecalciferol.
    Bobeck EA; Meyer KM; Helvig C; Petkovich M; Cook ME
    J Ren Nutr; 2013 Jan; 23(1):21-7. PubMed ID: 22406121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA; Shepler BM
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
    Brewster UC; Ciampi MA; Abu-Alfa AK; Reilly RF
    Nephrology (Carlton); 2006 Apr; 11(2):142-6. PubMed ID: 16669977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency.
    Nagano N; Miyata S; Obana S; Kobayashi N; Fukushima N; Burke SK; Wada M
    Nephrol Dial Transplant; 2003 Oct; 18(10):2014-23. PubMed ID: 13679475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperphosphataemia and treatment with sevelamer in haemodialysis patients.
    Cizman B
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v47-9. PubMed ID: 12817070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphate-Responsive Biomimetic Nanofluidic Diodes Regulated by Polyamine-Phosphate Interactions: Insights into Their Functional Behavior from Theory and Experiment.
    Pérez-Mitta G; Marmisollé WA; Albesa AG; Toimil-Molares ME; Trautmann C; Azzaroni O
    Small; 2018 May; 14(18):e1702131. PubMed ID: 29024459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure.
    Chertow GM; Burke SK; Lazarus JM; Stenzel KH; Wombolt D; Goldberg D; Bonventre JV; Slatopolsky E
    Am J Kidney Dis; 1997 Jan; 29(1):66-71. PubMed ID: 9002531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
    Nolan CR; Qunibi WY
    Kidney Int Suppl; 2005 Jun; (95):S13-20. PubMed ID: 15882308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis.
    Raggi P; James G; Burke SK; Bommer J; Chasan-Taber S; Holzer H; Braun J; Chertow GM
    J Bone Miner Res; 2005 May; 20(5):764-72. PubMed ID: 15824849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of RenaGel, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats.
    Rosenbaum DP; Holmes-Farley SR; Mandeville WH; Pitruzzello M; Goldberg DI
    Nephrol Dial Transplant; 1997 May; 12(5):961-4. PubMed ID: 9175050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemia.
    Akizawa T; Origasa H; Kameoka C; Kaneko Y; Kawasaki S;
    Ther Apher Dial; 2014 Apr; 18(2):122-31. PubMed ID: 24720402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleiotropic effects of the non-calcium phosphate binder sevelamer.
    Nikolov IG; Joki N; Maizel J; Lacour B; Drüeke TB; Massy ZA
    Kidney Int Suppl; 2006 Dec; (105):S16-23. PubMed ID: 17136111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of efficient phosphate binding on bone in chronic renal failure rats.
    Behets GJ; Gritters M; Dams G; De Broe ME; D'Haese PC
    Ren Fail; 2005; 27(4):475-84. PubMed ID: 16060138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
    Hervás JG; Prados D; Cerezo S
    Kidney Int Suppl; 2003 Jun; (85):S69-72. PubMed ID: 12753270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sevelamer, a phosphate-binding polymer, is a non-absorbed compound.
    Plone MA; Petersen JS; Rosenbaum DP; Burke SK
    Clin Pharmacokinet; 2002; 41(7):517-23. PubMed ID: 12083979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial.
    Chertow GM; Dillon MA; Amin N; Burke SK
    J Ren Nutr; 2000 Jul; 10(3):125-32. PubMed ID: 10921533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.